This change could be short lived. Just think about the near term catalysts that could be the new material. BTD for NASH & mTNBC. Covid 19 EUA? I think the trial will yield good results. HIV Resubmission.

Possibly a new look with a focus on where this Biotech/Pharmaceutical company is heading.